Home » Topics » BioWorld

BioWorld
RSS

SYNERGEN OFFERS TO BUY PARTNER

July 19, 1991

AMGEN REPORTS $48.4 MILLION LOSS

July 19, 1991

G-CSF REDUCES CHEMO SIDE EFFECT

July 19, 1991

CYTRX GETS MILESTONE PAYMENT FOR RHEOTHRX

July 19, 1991

XOMA TO LICENSE PROTEIN TECHNOLOGY

July 19, 1991

MICE MODELS FOR ALZHEIMER'S RESEARCH

July 18, 1991

OSTEOTECH COMPLETES IPO

July 18, 1991

SENATOR PROBES ORPHAN DRUG ABUSE

July 18, 1991

BINDING PARTNER FOR CELL-ADHESION MOLECULE

July 18, 1991

NIH GRANTS AZT RIGHTS TO BARR

July 18, 1991

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 30, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Regulatory actions for July 27, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Alfasigma,...